Melanie Braig

2.6k total citations · 1 hit paper
22 papers, 1.8k citations indexed

About

Melanie Braig is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Melanie Braig has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Hematology and 5 papers in Genetics. Recurrent topics in Melanie Braig's work include Chronic Myeloid Leukemia Treatments (9 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Melanie Braig is often cited by papers focused on Chronic Myeloid Leukemia Treatments (9 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Melanie Braig collaborates with scholars based in Germany, Switzerland and United Kingdom. Melanie Braig's co-authors include Clemens A. Schmitt, Soyoung Lee, Christoph Loddenkemper, Antoine H.F.M. Peters, Thomas Jenuwein, Brigitte Schlegelberger, Bernd Dörken, Cornelia Rudolph, Harald Stein and Stefan Balabanov and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Melanie Braig

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogene-induced senescence as an initial barrier in lymphoma development

2005 969 citations Melanie Braig, Soyoung Lee et al. Nature profile →

Peers

Countries citing papers authored by Melanie Braig

Since Specialization

Citations

This map shows the geographic impact of Melanie Braig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Braig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Braig more than expected).

Fields of papers citing papers by Melanie Braig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Braig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Braig. The network helps show where Melanie Braig may publish in the future.

Co-authorship network of co-authors of Melanie Braig

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Braig. A scholar is included among the top collaborators of Melanie Braig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Braig. Melanie Braig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biological Relevance and Therapeutic Potential of the Hypusine Modification System 2015 ·Journal of Biological Chemistry ·Nora Pällmann, Melanie Braig, Henning Sievert, (unknown), Irm Hermans‐Borgmeyer, Michaela Schweizer, (unknown), Melanie Neumann, Peter J. Wild, Eugenia Haralambieva, Christian Hagel, Carsten Bokemeyer, Joachim Hauber, Stefan Balabanov	41
2	A novel mouse model for inhibition of DOHH mediated hypusine modification reveals crucial function for embryonic development, proliferation and oncogenic transformation 2014 ·Disease Models & Mechanisms ·Henning Sievert, Nora Pällmann, Katharine K. Miller, Irm Hermans‐Borgmeyer, Simone Venz, Ataman Sendoel, (unknown), Michaela Schweizer, (unknown), Philipp Christoph Janiesch, Thomas Streichert, Reinhard Walther, Michael O. Hengartner, Markus G. Manz, Tim H. Brümmendorf, Carsten Bokemeyer, Melanie Braig, Joachim Hauber, Kent E. Duncan, Stefan Balabanov	45
3	A ‘telomere-associated secretory phenotype’ cooperates with BCR-ABL to drive malignant proliferation of leukemic cells 2014 ·Leukemia ·Melanie Braig, Nora Pällmann, (unknown), Doris Steinemann, Winfried Hofmann, Anne Gompf, Thomas Streichert, Till Braunschweig, Mhairi Copland, K. Lenhard Rudolph, Carsten Bokemeyer, Steffen Koschmieder, Andreas Schuppert, Stefan Balabanov, Tim H. Brümmendorf	32
4	Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia 2014 ·Drug Discovery Today Technologies ·Stefan Balabanov, Melanie Braig, Tim H. Brümmendorf	57
5	Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors 2013 ·PLoS ONE ·Stefan Balabanov, Thomas Wilhelm, Simone Venz, Gunhild Keller, Christian Scharf, Heike Pospisil, Melanie Braig, Christine Barett, Carsten Bokemeyer, Reinhard Walther, Tim H. Brümmendorf, Andreas Schuppert	5
6	The expression of podocyte-specific proteins in parietal epithelial cells is regulated by protein degradation 2013 ·Kidney International ·(unknown), Marlies Sachs, (unknown), Jan U. Becker, Tobias Meyer, (unknown), Saskia Schlossarek, Lucie Carrier, Melanie Braig, Parmjit Jat, Rolf A.K. Stahl, Catherine Meyer‐Schwesinger	34
7	BCR-ABL Cooperates With a “Telomere-Associated Secretory Phenotype” (TASP) To Facilitate Malignant Proliferation Of Hematopoietic Stem Cells 2013 ·Blood ·Tim H. Brümmendorf, Nora Pällmann, (unknown), Doris Steinemann, Winfried Hofmann, Anne Gompf, K. Lenhard Rudolph, Carsten Bokemeyer, Steffen Koschmieder, Andreas Schuppert, Stefan Balabanov, Melanie Braig	2
8	Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias 2012 ·Investigational New Drugs ·Patrick Ziegler, (unknown), Thomas Wilhelm, (unknown), Melanie Braig, (unknown), Susanne Ziegler, (unknown), Chris Meier, (unknown), Matthias Rarey, Jens Panse, Joachim Hauber, Stefan Balabanov, Tim H. Brümmendorf	9
9	Molecular characterization of chromosomal band 5p15.33: A recurrent breakpoint region in mantle cell lymphoma involving the TERT–CLPTM1L locus 2012 ·Leukemia Research ·Georgia Schilling, Eva Maria Murga Penas, (unknown), Leticia Oliveira‐Ferrer, Melanie Braig, (unknown), Carsten Bokemeyer, Judith Dierlamm	12
10	The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature 2012 ·Cancer Letters ·Leticia Oliveira‐Ferrer, Jasmin Wellbrock, Melanie Braig, (unknown), Jessica Hauschild, Carsten Bokemeyer, Walter Fiedler, Süleyman Ergün, Gunter Schuch	3
11	Protein-protein-interaction Network Organization of the Hypusine Modification System 2012 ·Molecular & Cellular Proteomics ·Henning Sievert, Simone Venz, (unknown), Vishnu M. Dhople, (unknown), Claus‐Henning Nagel, Melanie Braig, (unknown), Nora Pällmann, Carsten Bokemeyer, Tim H. Brümmendorf, Ralf Pörtner, Reinhard Walther, Kent E. Duncan, Joachim Hauber, Stefan Balabanov	15
12	Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies 2012 ·PLoS ONE ·(unknown), Christian Hagel, Alexander Schulte, Kristoffer Weber, Katrin Lamszus, Henning Sievert, Nora Pällmann, Carsten Bokemeyer, Joachim Hauber, Melanie Braig, Stefan Balabanov	55
13	Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro 2011 ·PLoS ONE ·Stefan Balabanov, Artur Gontarewicz, Gunhild Keller, Laura Raddrizzani, Melanie Braig, Roberta Bosotti, Jürgen Moll, Edgar Jost, Christine Barett, (unknown), Carsten Bokemeyer, Tessa L. Holyoake, Tim H. Brümmendorf	33
14	Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation 2011 ·Molecular Cancer ·Ramesh Ummanni, Edgar Jost, Melanie Braig, (unknown), (unknown), Christine Barett, Thorsten Schlomm, Guido Sauter, Tina Senff, Carsten Bokemeyer, Holger Sültmann, Catherine Meyer‐Schwesinger, Tim H. Brümmendorf, Stefan Balabanov	85
15	Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL–positive CML cells 2010 ·Experimental Hematology ·Ute Brassat, Stefan Balabanov, (unknown), Judith Dierlamm, Melanie Braig, Ulrike Hartmann, Hüseyin Sirma, Çagatay Güneş, Henning Wege, Boris Fehse, Artur Gontarewicz, Ekkehard Dikomey, Kerstin Borgmann, Tim H. Brümmendorf	25
16	Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model 2009 ·Neoplasia ·Daniel Benten, Gunhild Keller, Alexander Quaas, Jörg Schrader, Artur Gontarewicz, Stefan Balabanov, Melanie Braig, Henning Wege, Jürgen Moll, Ansgar W. Lohse, Tim H. Brümmendorf	56
17	Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy 2009 ·Hematological Oncology ·Gunhild Keller, Ute Brassat, Melanie Braig, (unknown), Henning Wege, Tim H. Brümmendorf	26
18	Resistance to Danusertib (formerly PHA-739358) in BCR-ABL-Positive Cells Is Mediated by Upregulation of the Drug Transporter Abcg2 and Can Be Suppressed in Vitro by Combination Treatment with Imatinib. 2009 ·Blood ·Tim H. Brümmendorf, Artur Gontarewicz, Gunhild Keller, Jürgen Moll, Melanie Braig, (unknown), Edgar Jost, Oliver Galm, Carsten Bokemeyer, Tessa L. Holyoake, Stefan Balabanov	2
19	Oncogene-Induced Senescence: Putting the Brakes on Tumor Development 2006 ·Cancer Research ·Melanie Braig, Clemens A. Schmitt	188
20	Oncogene-induced senescence as an initial barrier in lymphoma development breakdown → 2005 ·Nature ·Melanie Braig, Soyoung Lee, Christoph Loddenkemper, Cornelia Rudolph, Antoine H.F.M. Peters, Brigitte Schlegelberger, Harald Stein, Bernd Dörken, Thomas Jenuwein, Clemens A. Schmitt	969

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact